SCHEMBL6289860

SCHEMBL6289860

Nc1cccc(Oc2cccc(Oc3cccc(Oc4ccc(Oc5cccc(Oc6ccc(Oc7cccc(Oc8cccc(Oc9cccc(N)c9)c8)c7)cc6)c5)cc4)c3)c2)c1

nearest known ligand 0.95

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.83
ALDH1A1 P00352 5/20 0.78
SMN1; SMN2 Q16637 2/20 0.78
MEN1 O00255 2/20 0.78
KMT2A Q03164 2/20 0.78
MAPT P10636 2/20 0.78
MITF O75030 1/20 0.78
GAA P10253 1/20 0.78
GFER P55789 1/20 0.78
NLRP1 Q9C000 1/20 0.78
NOD2 Q9HC29 1/20 0.78
NPC1 O15118 1/20 0.61
RAB9A P51151 1/20 0.61
NLRP3 Q96P20 1/20 0.61
POLB P06746 1/20 0.59
HSP90AA1 P07900 1/20 0.59
CYP3A4 P08684 4/20 0.58
ATM Q13315 1/20 0.58
MAOA P21397 1/20 0.56
LTA4H P09960 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6293107 1.00 MAOB (0.83) MAOBALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL6290736 1.00 MAOB (0.83) MAOBALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL1270895 1.00 MAOB (0.83) MAOBALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL6290416 1.00 MAOB (0.83) MAOBALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL6289879 1.00 MAOB (0.83) MAOBALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL6289963 1.00 MAOB (0.83) MAOBALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL6290567 1.00 MAOB (0.83) MAOBALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL6290749 1.00 MAOB (0.83) MAOBALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL6293819 1.00 MAOB (0.83) MAOBALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL6290723 1.00 MAOB (0.83) MAOBALDH1A1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6933411-B2 Aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2005-08-23 US disclosed
US-6737503-B2 LOW TEMPERATURE ADHESIVE BONDING MITSUI CHEMICALS, INC. (JP) 2004-05-18 US disclosed
US-20040082754-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2004-04-29 US disclosed
US-20030092870-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2003-05-15 US disclosed
EP-1288191-A2 Novel aromatic diamine and polyimide thereof Mitsui Chemicals, Inc. (JP) 2003-03-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092870-A1 Novel aromatic diamine and polyimide thereof DDT, AOC1, H1-4 MAOB 368/4885ALDH1A1 902/4885SMN1; SMN2 2287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.